Test description
Testing (next generation sequencing) for IDH1 and FGFR2 variants in tumour tissue in patients with histologically confirmed cholangiocarcinoma. Information from this test will assist in determining eligibility for a relevant therapy under the PBS.
Test information
Test name
IDH1/FGFR2
Clinical indication
Testing for patients with histologically confirmed cholangiocarcinoma. Information from this test will assist in determining eligibility for a relevant therapy under the PBS.
Gene(s)
IDH1 and FGFR2
Method
NGS Oncomine Precision Assay
Turn around time
5 business days*
Medicare eligibility
73329 criteria apply
Price
If not MBS eligible. Please contact 1800 822 999 for pricing details
Test request form
Standard pathology request form
Sample type
FFPE Tumour Tissue
Collection type
N/A
Special instructions
6 x 5 micron slides plus 1 x H&E stained slide required. *TAT is from receipt of slides into lab.
FAQ
No items found.
Resources
No items found.